Having developed a compelling portfolio of intellectual property, ARP is now seeking like-minded partners to bring this exciting technology to global markets. The product is currently not being marketed in any region.

A significant partnering opportunity exists for the introduction of a clinically proven, long-term and safe alternative to current treatments for OA. For the millions of sufferers worldwide, the introduction of such a product would provide welcome relief from pain, without the side-affects associated with many existing treatment regimes.

Key points

  • Global/Regional commercialisation rights available.
  • Proven efficacy and safety.
  • Potential for treatments of other conditions.
  • Potential for new products/intellectual property from the platform which has broad scope of patent protection.
  • Suitable for Human and Veterinary Markets.

For further information regarding licensing opportunities please contact: [email protected]